National Medicines Regulatory Authority Act 2015 · As enacted · Part IV · General
31. Constitution of the National Advisory Committee
Official English translation. Where it differs from the Sinhala or Tamil text, the Act itself says which text prevails.
Official translationFrom Department of Government Printing, unchanged
The National Advisory Committee shall consist of the following members appointed by the Minister -
the Director General of Health Services;
the Deputy Director General of Health Services
(Laboratory Services);
the Chairman of the Authority;
a nominee from the Secretary to the Treasury;
the Chairman of the State Pharmaceuticals
Corporation of Sri Lanka established under State
Industrial Corporation Act, No. 49 of 1957;
a Professor in Pharmacology in any University in
Sri Lanka established under the Universities Act,
No. 16 of 1978, appointed in consultation with the respective Deans of the relevant Medical Faculties;
a Pharmacologist from the Ministry of Health nominated by the Director General of Health
Services;
the President of the Sri Lanka Medical Association or his nominee;
the President of the Pharmaceutical Society of Sri
Lanka or his nominee;
the Commissioner of Ayurveda or his nominee;
Director General of Customs or his nominee;
a legal officer from the Ministry of Health nominated by the Secretary;
a representative of the Ceylon College of
Physicians nominated by that College;
a representative of the College of Surgeons of Sri
Lanka nominated by that College;
a representative of the College of General
Practitioners of Sri Lanka nominated by that
College;
a representative of the College of Community
Physicians of Sri Lanka nominated by that College;
a representative from the Attorney General’s
Department nominated by the Attorney General;
a representative from the Consumer Affairs
Authority nominated by the Chairman of that
Authority;
a representative of the Sri Lanka Standards
Institution established under the Sri Lanka
Standards Institution Act, No. 6 of 1984, nominated by the Director General of such Institution;
a representative from a patient interest group nominated by the Minister of Health;
a representative from the Sri Lanka Pharmaceutical
Manufacturers Association nominated by that
Association;
a representative from the Sri Lanka Chamber of the
Pharmaceutical Industry nominated by such
Chamber;
a representative of the public nominated by the
Minister; and
a representative of the Senaka Bibile
Commemoration Committee.
Every member of the National Advisory Committee nominated under paragraphs (m), (n), (o), (p), (q), (r), (s), (t),(u),(v), (w) and (x) of subsection (1) shall, unless earlier vacates office by resignation, death or removal, hold office for a period of three years from the date of appointment and shall be eligible for re-appointment.
Every other member of the National Advisory
Committee shall hold office so long as such member holds office by virtue of which such member has been appointed to the National Advisory Committee.
Part V
General
Part VI
Rules and Regulations
Part VII
Repeals and Transitional Provisions
Part VIII